VOLITIONRX LTD (VNRX)
US9286611077 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to VNRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.15. This target is 412.74% above the current price.
VNRX was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about VNRX.
In the previous month the buy percentage consensus was at a similar level.
VNRX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-16 | Benchmark | Reiterate | Hold |
| 2024-06-07 | EF Hutton | Maintains | Buy -> Buy |
| 2024-05-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-05-14 | EF Hutton | Maintains | Buy -> Buy |
| 2024-03-27 | EF Hutton | Maintains | Buy -> Buy |
| 2024-03-27 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-01-02 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-11-21 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-11-16 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-10-30 | EF Hutton | Initiate | Buy |
| 2023-08-16 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-03-16 | EF Hutton | Reiterate | Buy |
| 2023-02-01 | Benchmark | Downgrade | Buy -> Hold |
| 2022-12-19 | EF Hutton | Initiate | Buy |
| 2022-08-23 | Maxim Group | Maintains | Buy |
| 2022-08-15 | Aegis Capital | Maintains | Buy |
| 2021-11-16 | Aegis Capital | Maintains | Buy |
| 2021-03-10 | Cantor Fitzgerald | Initiate | Overweight |